Natalie Stickle
Overview
Explore the profile of Natalie Stickle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cordeiro B, Ahn J, Gawde S, Ucciferri C, Alvarez-Sanchez N, Revelo X, et al.
Cell Metab
. 2024 Aug;
36(10):2298-2314.e11.
PMID: 39168127
Obesity has been implicated in the rise of autoimmunity in women. We report that obesity induces a serum protein signature that is associated with T helper 1 (Th1), interleukin (IL)-17,...
2.
Kondratyev M, Pesic A, Ketela T, Stickle N, Beswick C, Shalev Z, et al.
Commun Biol
. 2023 May;
6(1):538.
PMID: 37202533
During cancer development, tumor cells acquire changes that enable them to invade surrounding tissues and seed metastasis at distant sites. These changes contribute to the aggressiveness of metastatic cancer and...
3.
Toma A, Dos Santos C, Burzynska B, Gora M, Kiliszek M, Stickle N, et al.
Circ Res
. 2022 May;
131(1):106-108.
PMID: 35534922
No abstract available.
4.
Ng S, Murphy T, King I, Zhang T, Mah M, Lu Z, et al.
Blood Adv
. 2021 Dec;
6(3):1064-1073.
PMID: 34872104
Leukemia stem cells (LSCs) are linked to relapse in acute myeloid leukemia (AML). The LSC17 gene expression score robustly captures LSC stemness properties in AML and can be used to...
5.
Tone A, McCuaig J, Ricker N, Boghosian T, Romagnuolo T, Stickle N, et al.
Gynecol Oncol
. 2021 Apr;
162(1):97-106.
PMID: 33858678
Background: Up to 20% of high-grade serous ovarian carcinomas (HGSOC) are hereditary; however, historical uptake of genetic testing is low. We used a unique combination of approaches to identify women...
6.
Care M, McCuaig J, Clarke B, Grenier S, Kim R, Rouzbahman M, et al.
Mol Oncol
. 2020 Oct;
15(1):80-90.
PMID: 33030818
The aim of this study was to determine the prevalence of somatic and germline pathogenic variants (PVs) in high-grade serous cancer (HGSC) and to demonstrate the technical feasibility and effectiveness...
7.
Yoon J, Marino-Enriquez A, Stickle N, de Borja R, Ismiil N, Djordjevic B, et al.
Mod Pathol
. 2019 Jun;
32(11):1688-1697.
PMID: 31189997
Uterine myxoid smooth muscle tumors, including myxoid leiomyosarcoma, are rare and their genomic profile has not been fully characterized. With the discovery of uterine sarcomas with ZC3H7B-BCOR fusion and BCOR...
8.
Sukhai M, Misyura M, Thomas M, Garg S, Zhang T, Stickle N, et al.
J Mol Diagn
. 2018 Dec;
21(2):261-273.
PMID: 30576869
A common approach in clinical diagnostic laboratories to variant assessment from tumor molecular profiling is sequencing of genomic DNA extracted from both tumor (somatic) and normal (germline) tissue, with subsequent...
9.
Cybulska P, Stewart J, Sayad A, Virtanen C, Shaw P, Clarke B, et al.
Am J Pathol
. 2018 Feb;
188(5):1120-1131.
PMID: 29458007
High-grade serous ovarian cancer (HGSC) is the leading cause of morbidity and mortality from gynecologic malignant tumors. Overall survival remains low because of the nearly ubiquitous emergence of platinum resistance...
10.
Lobo N, Gedye C, Apostoli A, Brown K, Paterson J, Stickle N, et al.
BMC Cancer
. 2016 Jul;
16:485.
PMID: 27422173
Background: Patients with clear cell renal cell carcinoma (ccRCC) have few therapeutic options, as ccRCC is unresponsive to chemotherapy and is highly resistant to radiation. Recently targeted therapies have extended...